Polycystic Ovarian Syndrome and Insulin Resistance: Implications for Estrogen Use in Premenopausal and Postmenopausal Women
- 1 September 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Metabolic Syndrome and Related Disorders
- Vol. 3 (3), 259-269
- https://doi.org/10.1089/met.2005.3.259
Abstract
Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive age women, affecting an estimated 8–10% of all women in this age group or approximately six million women. Further, women with PCOS continue to manifest the metabolic alterations inherent in the insulin resistance syndrome after menopause, rendering them more susceptible to type 2 diabetes and cardiovascular disease. Aging and obesity further contribute to these risks. Since estrogen-containing therapy is commonly used for menstrual regulation in premenopausal women with PCOS, it is important to evaluate the possible consequences of hormonal therapy on subsequent metabolic and cardiovascular risk. In postmenopausal women, a consensus regarding the appropriate role of estrogen replacement therapy is currently in evolution. By examining the effects of estrogen with or without progesterone on insulin resistance, insight may be gained about the risk/benefit ratio of this therapy in the subset of women with insulin resistance, PCOS, and type 2 diabetes. The goal of this review, then, is to examine the known effects of estrogen on insulin sensitivity and its implications for cardiovascular and metabolic risk.Keywords
This publication has 67 references indexed in Scilit:
- Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndromeJournal of Endocrinology, 2005
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationJournal of Clinical Endocrinology & Metabolism, 2004
- Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndromeHuman Reproduction, 2004
- Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndromeMetabolism, 2003
- Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2002
- Mechanisms of Hypothalamic-Pituitary-Gonadal Disruption in Polycystic Ovarian SyndromeArchives of Medical Research, 2001
- Serum testosterone levels decrease in middle age in women with the polycystic ovary syndromeFertility and Sterility, 2000
- Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care, 1999
- Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected WomenJournal of Clinical Endocrinology & Metabolism, 1999
- 17 -Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight LossJournal of Clinical Endocrinology & Metabolism, 1997